Story behind the clinical trial of B.663 in leprosy.
D000818:Animals; D000995:Antitubercular Agents / Q000627:therapeutic use*; D006801:Humans; D007918:Leprosy / Q000188:drug therapy*; D051379:Mice; D010619:Phenazines / Q000627:therapeutic use*
D000995:Antitubercular Agents; D010619:Phenazines